Heightened BRAF and BRAF pseudogene expression levels in 2 Japanese patients with Erdheim‐Chester disease
Journal of Cutaneous Immunology and Allergy · 2018
DOI: 10.1002/cia2.12010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cutaneous Immunology and Allergy, 2018. Verfasst von Yukako Murakami und 7 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Erdheim‐Chester disease ( ECD ) is a rare form of non‐Langerhans cell histiocytosis with multi‐organ involvement. Many cases have mutations in the BRAF and other genes involved in the MAPK activation pathway. Pseudogenes, which regulate their parental genes post‐transcriptionally, are overexpressed in various tumors, but we found no previous reports of high pseudogene expression in ECD .
Methods
We evaluated the xanthoma tissues of two patients with ECD . BRAF from the genomic DNA of the tissue was amplified by the polymerase chain reaction ( PCR ). The amplified fragment was directly sequenced to search the BRAFV 600E mutation. Real‐time PCR was performed to amplify cDNA via primer sets specific for either BRAF or BRAF pseudogenes.
Results
The first case, with advanced stable ECD , expressed high levels of BRAF pseudogenes and BRAF , and a low frequency of the BRAFV 600E mutation. The second case, with early active ECD , showed high expression levels of both BRAF pseudogenes and BRAF gene but no BRAFV 600E mutation.
Discussion
In the early‐stage of ECD , high levels of BRAF pseudogene expression may boost BRAF expression, promoting the proliferation of xanthomas. The BRAF ‐V600E mutation may be associated with advanced stable stage.
Conclusion
This is the first report of ECD without a BRAFV 600E mutation and with elevated BRAF gene and BRAF pseudogene expression. The etiologic ramifications of BRAF or BRAF pseudogenes in patents with ECD will be the focus of future study.
Zitieren
APA
Murakami, Y., Wataya‐Kaneda, M., Kitayama, K., Arase, N., Murota, H., Hirayasu, K., Arase, H., & Katayama, I. (2018). Heightened BRAF and BRAF pseudogene expression levels in 2 Japanese patients with Erdheim‐Chester disease. Journal of Cutaneous Immunology and Allergy. https://doi.org/10.1002/cia2.12010
Vancouver
Murakami Y, Wataya‐Kaneda M, Kitayama K, Arase N, Murota H, Hirayasu K, et al. Heightened BRAF and BRAF pseudogene expression levels in 2 Japanese patients with Erdheim‐Chester disease. Journal of Cutaneous Immunology and Allergy. 2018. doi:10.1002/cia2.12010
BibTeX
@article{Murakami2018,
author = {Murakami, Yukako and Wataya‐Kaneda, Mari and Kitayama, Kazuko and Arase, Noriko and Murota, Hiroyuki and Hirayasu, Kouyuki and Arase, Hisashi and Katayama, Ichiro},
title = {Heightened BRAF and BRAF pseudogene expression levels in 2 Japanese patients with Erdheim‐Chester disease},
journal = {Journal of Cutaneous Immunology and Allergy},
year = {2018},
doi = {10.1002/cia2.12010}
}
EUVIMED